Vor Biopharma Inc. cotiza a 19.06 USD y tiene una capitalización bursátil de $1.1B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as we…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.73 | $307.53 |
| Estimado | $-0.77 | $-0.70 | $-0.78 | $-1.19 |
| Sorpresa | — | — | +6.4% | +25942.9% |
| Métrica | VOR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -150.0% | -32.0% | -118.0% |
| Current Ratio | 18.20 | 2.84 | +15.36 |
| Debt / Equity | — | 0.28 | — |